Natalie Malone, Gabriella R Pitcher, Destin L Mizelle, Paris Wheeler, Brittany Miller-Roenigk, Kendall A McCleod, Mekaila Keeling, Tristan Ntego, Candice N Hargons, Danelle Stevens-Watkins
{"title":"\"吸毒与种族主义......我想做这项研究的原因\":使用阿片类药物的美国黑人对种族和种族主义对药物使用影响的看法》。","authors":"Natalie Malone, Gabriella R Pitcher, Destin L Mizelle, Paris Wheeler, Brittany Miller-Roenigk, Kendall A McCleod, Mekaila Keeling, Tristan Ntego, Candice N Hargons, Danelle Stevens-Watkins","doi":"10.1080/10826084.2024.2423371","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: Several studies link racism with drug use disparities among systemically marginalized populations. However, few invite Black Americans to discuss how they perceive racism's impact on their drug use. <b>Objectives</b>: To examine qualitative accounts from N=40 Black adults reporting non-medical prescription opioid use on their experiences of racism and drug use. <b>Results</b>: A deductive structural tabular thematic analysis informed by Jones's (2000) levels of racism resulted in two themes: (a) Experiences of Racism (subthemes: Denying Experiences of Racism and Endorsing Experiences of Racism) and (b) Race, Racism, and Drug Use (subthemes: Rejecting Race and Racism's Impact on Drugs and Rejecting Race and Racism's Impact on Drugs). <b>Conclusions</b>: Participants provided examples of internalized, personally mediated, and institutionalized racism associated with their drug use. Implications for policy, practice, and research are discussed. Specifically, implications detail how to center Black Americans and demonstrate anti-racism when developing treatment strategies and drug policies.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"265-275"},"PeriodicalIF":1.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"\\\"Drug Use with Racism…The Reason I Wanted to Do This Study\\\": Perceptions of Race and Racism's Impact on Drug Use among Black Americans Using Opioids.\",\"authors\":\"Natalie Malone, Gabriella R Pitcher, Destin L Mizelle, Paris Wheeler, Brittany Miller-Roenigk, Kendall A McCleod, Mekaila Keeling, Tristan Ntego, Candice N Hargons, Danelle Stevens-Watkins\",\"doi\":\"10.1080/10826084.2024.2423371\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background</b>: Several studies link racism with drug use disparities among systemically marginalized populations. However, few invite Black Americans to discuss how they perceive racism's impact on their drug use. <b>Objectives</b>: To examine qualitative accounts from N=40 Black adults reporting non-medical prescription opioid use on their experiences of racism and drug use. <b>Results</b>: A deductive structural tabular thematic analysis informed by Jones's (2000) levels of racism resulted in two themes: (a) Experiences of Racism (subthemes: Denying Experiences of Racism and Endorsing Experiences of Racism) and (b) Race, Racism, and Drug Use (subthemes: Rejecting Race and Racism's Impact on Drugs and Rejecting Race and Racism's Impact on Drugs). <b>Conclusions</b>: Participants provided examples of internalized, personally mediated, and institutionalized racism associated with their drug use. Implications for policy, practice, and research are discussed. Specifically, implications detail how to center Black Americans and demonstrate anti-racism when developing treatment strategies and drug policies.</p>\",\"PeriodicalId\":22088,\"journal\":{\"name\":\"Substance Use & Misuse\",\"volume\":\" \",\"pages\":\"265-275\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Substance Use & Misuse\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10826084.2024.2423371\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Use & Misuse","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10826084.2024.2423371","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
"Drug Use with Racism…The Reason I Wanted to Do This Study": Perceptions of Race and Racism's Impact on Drug Use among Black Americans Using Opioids.
Background: Several studies link racism with drug use disparities among systemically marginalized populations. However, few invite Black Americans to discuss how they perceive racism's impact on their drug use. Objectives: To examine qualitative accounts from N=40 Black adults reporting non-medical prescription opioid use on their experiences of racism and drug use. Results: A deductive structural tabular thematic analysis informed by Jones's (2000) levels of racism resulted in two themes: (a) Experiences of Racism (subthemes: Denying Experiences of Racism and Endorsing Experiences of Racism) and (b) Race, Racism, and Drug Use (subthemes: Rejecting Race and Racism's Impact on Drugs and Rejecting Race and Racism's Impact on Drugs). Conclusions: Participants provided examples of internalized, personally mediated, and institutionalized racism associated with their drug use. Implications for policy, practice, and research are discussed. Specifically, implications detail how to center Black Americans and demonstrate anti-racism when developing treatment strategies and drug policies.
期刊介绍:
For over 50 years, Substance Use & Misuse (formerly The International Journal of the Addictions) has provided a unique international multidisciplinary venue for the exchange of original research, theories, policy analyses, and unresolved issues concerning substance use and misuse (licit and illicit drugs, alcohol, nicotine, and eating disorders). Guest editors for special issues devoted to single topics of current concern are invited.
Topics covered include:
Clinical trials and clinical research (treatment and prevention of substance misuse and related infectious diseases)
Epidemiology of substance misuse and related infectious diseases
Social pharmacology
Meta-analyses and systematic reviews
Translation of scientific findings to real world clinical and other settings
Adolescent and student-focused research
State of the art quantitative and qualitative research
Policy analyses
Negative results and intervention failures that are instructive
Validity studies of instruments, scales, and tests that are generalizable
Critiques and essays on unresolved issues
Authors can choose to publish gold open access in this journal.